Centene Corporation
$39.26
▲
0.31%
2026-04-22 10:12:13
www.centene.com
NYQ: CNC
Explore Centene Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$19.34 B
Current Price
$39.26
52W High / Low
$64.15 / $25.08
Stock P/E
—
Book Value
$40.58
Dividend Yield
—
ROCE
-0.78%
ROE
-28.68%
Face Value
—
EPS
$-13.53
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
61,100
Beta
0.59
Debt / Equity
90.56
Current Ratio
1.1
Quick Ratio
1.1
Forward P/E
9.15
Price / Sales
0.1
Enterprise Value
$16.29 B
EV / EBITDA
6.36
EV / Revenue
0.09
Rating
Hold
Target Price
$43.29
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Progyny, Inc. | $18.64 | 24.25 | $1.42 B | — | 15.79% | 12.48% | $28.75 / $16.1 | $6.24 |
| 2. | Alignment Healthcare, Inc. | $21.56 | — | $4.34 B | — | 2.9% | -0.7% | $23.87 / $11.62 | $0.88 |
| 3. | Clover Health Investments, Corp. | $2.23 | — | $1.15 B | — | -25.75% | -26.33% | $3.92 / $1.58 | $0.59 |
| 4. | Oscar Health, Inc. | $16.44 | — | $4.9 B | — | — | -44.35% | $23.8 / $10.69 | $3.29 |
| 5. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 6. | The Cigna Group | $279.79 | 12.61 | $73.76 B | 2.24% | — | 15.13% | $350 / $239.51 | $158.32 |
| 7. | Molina Healthcare, Inc. | $153.28 | 17.21 | $8.02 B | — | 9.53% | 11.02% | $333.22 / $121.06 | $79.78 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 49.73 B | 49.69 B | 48.74 B | 46.62 B | 40.8 B | — |
| Operating Profit | -1.23 B | -211 M | -403 M | 1.53 B | 175 M | — |
| Net Profit | -1.1 B | -6.63 B | -253 M | 1.31 B | 283 M | — |
| EPS in Rs | -2.24 | -13.48 | -0.51 | 2.67 | 0.58 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 194.78 B | 163.07 B | 154 B | 144.55 B |
| Operating Profit | -312 M | 3.19 B | 3.46 B | 3.64 B |
| Net Profit | -6.67 B | 3.31 B | 2.7 B | 1.2 B |
| EPS in Rs | -13.57 | 6.72 | 5.49 | 2.44 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 76.75 B | 82.44 B | 84.64 B | 76.87 B |
| Total Liabilities | 56.69 B | 55.94 B | 58.69 B | 52.63 B |
| Equity | 19.95 B | 26.41 B | 25.84 B | 24.06 B |
| Current Assets | 40.37 B | 38 B | 40.76 B | 30.13 B |
| Current Liabilities | 36.7 B | 34.26 B | 36.72 B | 28.46 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 5.09 B | 154 M | 8.05 B | 6.26 B |
| Investing CF | 472 M | -1.05 B | -1.19 B | -2.92 B |
| Financing CF | -1.62 B | -2.41 B | -1.66 B | -4.2 B |
| Free CF | 4.32 B | -490 M | 7.25 B | 5.26 B |
| Capex | -767 M | -644 M | -799 M | -1 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 5.89% | 6.54% | — | — |
| Earnings Growth % | 22.32% | 124.79% | — | — |
| Profit Margin % | 2.03% | 1.75% | 0.83% | — |
| Operating Margin % | 1.95% | 2.25% | 2.52% | — |
| Gross Margin % | 10.32% | 11.24% | 11.52% | — |
| EBITDA Margin % | 3.8% | 3.65% | 2.81% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.